NEW YORK (GenomeWeb News) – The Multiple Myeloma Research Foundation will collaborate with the Broad Institute of MIT and Harvard to study the genetics underlying multiple myeloma tumors.
MMRF will provide both patient samples for analysis and funding for the project, which will involve sequencing the whole genomes of the myeloma tumors. MMRF said that it will make all of the data from the collaboration publicly available.
MMRF CEO Kathy Giusti said in a statement that the foundation launched a collaboration three years ago with the Broad and with the Translational Genomics Research Institute called the Multiple Myeloma Genomics Initiative.
The information from the research will be used to add to the data currently catalogued in public resources on cancer biology, such as the Cancer Genome Atlas project.
"The few cancer genomes sequenced to date have been informative, but we need many more to transform cancer research and ultimately cancer therapy," Co-director of the Broad's Genome Sequencing and Analysis Program, Stacey Gabriel, said in a statement.